Home
_




 

 

 

 

Design of Small Molecule Therapeutics for the Treatment of Alzheimer’s Disease Based on the Discovery of Innovative Drug Targets

 

This web side is intended to facilitate communication amongst the project partners and to inform colleagues and the general public about the results of the project.


 

For any further queries please contact:


Project Coordinator: Dr. Georg C. Terstappen, Sienabiotech S.p.A. @ (info)
Project starting date: June 1, 2005
Duration of the Project: 5 Years
Partners of the Project: 8 (from 6 different countries)

 


Disclaimer: The contents of the ADIT web side are the sole responsibility of the project coordinator and do not necessarily represent the opinion of the European Community.

PRIORITY LSH-2003-1.2.1-3 Novel therapeutic substances for neurodegenerative diseases in CNS and PNS.